Shark cartilage drug AE-941 does not improve lung cancer survival

AE-941, a standardized shark cartilage, does not improve lung cancer survival – The anti-cancer drug AE-941, a shark cartilage derivative, did not improve overall survival in patients with inoperable stage III non-small cell lung cancer, according to a study published online May_26 in the Journal of the National Cancer Institute.

Health Newstrack